Showing results (3481-3490 of 11,104) with videos related to
Sort By:
Pageof 1,111
Journal of the National Cancer Institute|August 7, 1991
Thy-1 and T-cell receptor antigen expression in mycosis fungoides and benign inflammatory dermatosesD P Fivenson, L A Rheins, J J Nordlund, et al.Journal of the National Cancer Institute|June 22, 2006
Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradationMaen Abdelrahim, Cheryl H Baker, James L Abbruzzese, et al.Journal of the National Cancer Institute|July 5, 2006
Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor studyCharles A Sklar, Ann C Mertens, Pauline Mitby, et al.Journal of the National Cancer Institute|July 5, 2006
Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC)Tobias Pischon, Petra H Lahmann, Heiner Boeing, et al.Journal of the National Cancer Institute|September 21, 2006
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysisDavide Mauri, Nicholas Pavlidis, Nikolaos P Polyzos, et al.Journal of the National Cancer Institute|September 21, 2006
Rising incidence of small renal masses: a need to reassess treatment effectJohn M Hollingsworth, David C Miller, Stephanie Daignault, et al.Journal of the National Cancer Institute|April 1, 1975
Testing for possible effects of cedar wood shavings and diet on occurrence of mammary gland tumors and hepatomas in C3H-A-vy and C3H-Avy-fB miceW E HestonJournal of the National Cancer Institute|September 7, 2006
Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplificationShahab Asgharzadeh, Roger Pique-Regi, Richard Sposto, et al.Journal of the National Cancer Institute|September 7, 2006
Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic densityJinbo Chen, David Pee, Rajeev Ayyagari, et al.Journal of the National Cancer Institute|September 8, 2005
A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancerKim N Chi, Elizabeth Eisenhauer, Ladan Fazli, et al.Pageof 1,111